Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy Eric GuedjThomas GraillonDavid Taieb Letter to the Editor 14 December 2018 Pages: 537 - 538
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 Ian LawNathalie L. AlbertMichael Weller Guidelines Open access 05 December 2018 Pages: 540 - 557
18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions Olivier HumbertVéronique BourgJacques Darcourt Original Article 05 January 2019 Pages: 558 - 568
Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity Kenney Roy RoodakkerAli AlhuseinalkhudhurAnja Smits Original Article Open access 14 August 2018 Pages: 569 - 579
Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study Marcus UnterrainerD. F. FleischmannNathalie L. Albert Original Article 22 September 2018 Pages: 580 - 590
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma Philipp LohmannPantelis StavrinouNorbert Galldiks Original Article 16 October 2018 Pages: 591 - 602
Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma Michael LundemannPer Munck af RosenschöldAdam E. Hansen Original Article 02 October 2018 Pages: 603 - 613
Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma Leszek KrólickiFrank BruchertseiferAlfred Morgenstern Original Article 29 November 2018 Pages: 614 - 622
The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma Francesco GiammarileClare SchillingRoberto C. Delgado Bolton Guidelines Open access 18 December 2018 Pages: 623 - 637
PET-based prognostic survival model after radiotherapy for head and neck cancer Joël CastelliA. DepeursingeR. de Crevoisier Original Article 21 August 2018 Pages: 638 - 649
Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma Yu-Hung ChenKai-Ping ChangSheng-Chieh Chan Original Article 27 September 2018 Pages: 650 - 660
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage Alberta CappelliPaloma SangroBruno Sangro Original Article 12 September 2018 Pages: 661 - 668
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience Héloïse BourienXavier PalardJulien Edeline Original Article 29 October 2018 Pages: 669 - 676
Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors Simone KrebsNeeta Pandit-TaskarJoseph A. O’Donoghue Original Article 29 October 2018 Pages: 677 - 685
Early 18F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma Benjamin Leroy-FreschiniVincent AmodruAlessio Imperiale Original Article 07 January 2019 Pages: 686 - 695
Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation E. A. AalbersbergB. J. de Wit – van der VeenM. P. M. Stokkel Original Article 10 August 2018 Pages: 696 - 703
Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours W. A. van der ZwanT. BrabanderW. W. de Herder Original Article Open access 28 September 2018 Pages: 704 - 717
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN) Grace KongSimona Grozinsky-GlasbergRodney J. Hicks Original Article 20 October 2018 Pages: 718 - 727
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial Michela Del PreteFrançois-Alexandre ButeauJean-Mathieu Beauregard Original Article 30 November 2018 Pages: 728 - 742
Regulation of human brown adipose tissue by adenosine and A2A receptors – studies with [15O]H2O and [11C]TMSX PET/CT Minna LahesmaaVesa OikonenKirsi A. Virtanen Original Article Open access 13 August 2018 Pages: 743 - 750
Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis Giorgio TregliaArnoldo PiccardoLuca Giovanella Original Article 09 August 2018 Pages: 751 - 765
Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile Arnoldo PiccardoP. TrimboliL. Giovanella Original Article 15 September 2018 Pages: 766 - 775
Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI Christian Philipp ReinertMartin Ulrich SchuhmannSergios Gatidis Original Article 08 December 2018 Pages: 776 - 787
Ectopic corticotropin-releasing hormone syndrome caused by pancreatic neuroendocrine tumor localized by 68Ga-DOTATATE PET/CT Guozhu HouYuanyuan JiangWuying Cheng Image of the Month 05 December 2018 Pages: 788 - 788
Christopher E. Comstock, Christiane Kuhl (Eds.): Abbreviated MRI of the Breast: A Practical Guide Luigi Mansi Book Review 11 October 2018 Pages: 789 - 789
Bombardieri E, Seregni E, Evangelista L, Chiesa C, Chiti A (Eds.) Clinical Applications of Nuclear Medicine Targeted Therapy. Springer International Publishing Switzerland 2018. ISBN 978-3-319-63067-0 Luigi Mansi Book Review 31 October 2018 Pages: 790 - 790
